NEW YORK (TheStreet) -- CHANGE IN RATINGS:
Air T AIRT upgraded to buy at TheStreet Ratings.
Franklin Resources BEN was upgraded at Keefe, Bruyette & Woods from market perform to outperform. Valuation call, based on a $160 price target, KBW said.
Columbia Sportswear COLM was downgraded at Citigroup to sell from neutral. $45 price target. Changing environment and negative upcoming catalysts, Citi said.
Copart CPRT was downgraded at Baird from outperform to neutral. Valuation call, based on a $36 price target, Baird said.
Chevron CVX was downgraded at UBS to neutral from buy. $120 price target. Valuation call, UBS said.
Essex Property Trust ESS upgraded to buy at TheStreet Ratings.
Google GOOG was downgraded at BMO Capital to market perform. $790 price target. Valuation call, as the stock is up 39% since mid-June, BMO Capital said.
Hershey HSY was downgraded at Goldman Sachs from buy to neutral. Valuation call, based on an $86 price target. Company was also cut from the Conviction Buy list, Goldman said.
Mead Johnson MJN was upgraded at Goldman Sachs from neutral to buy. Company was also placed on the Conviction List. $95 price target. Company should see a material growth rebound in China, Goldman said.
Melco Crown Entertainment MPEL was upgraded at Jefferies to hold from underperform. $22.70 price target. Solid premium mas growth momentum, Jefferies said.
Merck MPEL was downgraded at Morgan Stanley from equal-weight to underweight. Company may see near-term weakness in its clinical portfolio, Morgan Stanley said.
Merck MRK was downgraded at Leerink Swann from outperform to market perform.Company lacks near-term catalysts, Leerink Swann said.
Norfolk Southern NSC was upgraded at Dahlman Rose from hold to buy. $82 price target. Company is leveraged to higher met coal pricing, Dahlman Rose said.
Perrigo PRGO was upgraded at Morgan Stanley from equal-weight to overweight. $125 price target. Nutritionals overhang has been lifted and the company has strong growth prospects, Morgan Stanley said.
Perrigo was upgraded at Canaccord from hold to buy. $128 price target. Company trades at a discount valuation and can deliver higher near-term earnings, Canaccord said.
Charles Schwab SCHW was downgraded at UBS to neutral from buy. $17 price target. Too much enthusiasm in valuation, UBS said.
Sandridge Energy MPEL was downgraded at Ladenburg Thalmann from buy to neutral. $7 price target. Company could deliver lower oil production in the Mississippian, Ladenburg Thalmann said.
Sempra Energy SRE was upgraded at J.P. Morgan to overweight. Company can continue to outperform in 2013, with Latin America and LNG as the main growth drivers, J.P. Morgan said.
St. Jude Medical STJ was upgraded at Credit Suisse from neutral to outperform. $48 price target. Left investor meeting with a more favorable outlook for Durata, Credit Suisse said.
Timken TKR was upgraded at Bank of America/Merrill Lynch to buy. Company is a well-run company that is leveraged to an eventual cyclical recovery, BofA/Merrill said.
Wesco International WCC was downgraded at UBS to neutral from buy. $75 price target. Few catalysts in the near term, UBS said.
Wal-Mart WMT was downgraded at J.P. Morgan from overweight to neutral. $75 price target.
Western Union WU was upgraded at Deutsche Bank from hold to buy. $19 price target. Market is setting up well for a company turnaround, Deutsche said.
Yahoo! YHOO was upgraded at Stifel Nicolaus from hold to buy. $25 price target. Alibaba and Yahoo Japan are rising in value, Stifel Nicolaus said.
STOCK COMMENTS / EPS CHANGES
AbbVie ABBV numbers raised at Jefferies. Shares of ABBV now seen reaching $45, Jefferies said. Estimates also raised on Humira continues to squeeze the bears. Buy rating.
Cisco Systems CSCO numbers raised at Oppenheimer. Shares of CSCO now seen reaching $24, Oppenheimer said. Estimates also raised on solid checks. Outperform rating.
Deckers Outdoor DECK numbers raised at Jefferies. Shares of DECK now seen reaching $60, Jefferies said. Estimates also raised on solid online trends and store checks. Buy rating.
Emerson EMR numbers raised at Oppenheimer. Shares of EMR now seen reaching $63, Oppenheimer said. Estimates also raised on recovery of premium. Perform rating.
FedEx FDX added to US 1 List at BofA/Merrill. FDX was placed on the US 1 list, Bank of America/Merrill Lynch said. Company is seeing positive volume trends and cutting costs. $122 price target.
Las Vegas Sands LVS numbers raised at Morgan Stanley. Shares of LVS now seen reaching $60, according to Morgan Stanley. Estimates also increased, given stronger growth in Macau. Overweight rating.
LyondellBasell LYB numbers raised at Jefferies. Shares of LYB now seen reaching $70, Jefferies said. Estimates also raised on favorable 2013 backdrop. Buy rating.
National Oilwell Varco NOV numbers lowered at Jefferies. Shares of NOV now seen reaching $86, Jefferies said. Estimates also lowered on longer- term rig tech conservatism. Buy rating.
Newell Rubbermaid NWL target raised at Oppenheimer to $27, Oppenheimer said. Game plan on track. Outperform rating.
PetSmart PETM added to US 1 List at BofA/Merrill. $85 price target. Company is leveraged to a favorable macro backdrop.
>To submit a news tip, email: firstname.lastname@example.org.
READERS ALSO LIKE: